EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 5 December 2019

Commission Proposal for a European Regulation on HTA: Europe cannot afford an inefficient system for joint clinical assessments

Commission Proposal for a European Regulation on HTA: Europe cannot afford an inefficient system...
29 November 2019

In light of the inclusion of the Commission Proposal for a European Regulation on HTA as an AOB at the 9 December EPSCO, EFPIA, representing the research-based pharmaceutical industry operating in Europe, expresses its strong concerns over the risk that EU member states will opt for what will inevitably lead to an inefficient system of joint clinical assessments. Europe needs to speak with a coherent voice on clinical evidence in the best interests of patients and our healthcare systems. Read more

Everyday counts: time to patient access to innovative oncology therapies in Europe

What factors delay access to new cancer medicines across Europe? Which best practices and what recommendations can improve time to patient access? Read our new blog post from Minxian Congé, Vice Chair of EFPIA Oncology Platform.

Improving health outcomes for people with diabetes

Every 6 seconds a person in Europe dies of a diabetes related condition.
Diabetes is a rapidly growing health crisis affecting around one in ten Europeans, that is around 60 million people in Europe, with type 2 diabetes accounting for more than 90% of all cases. Watch the highlight video from our event held on 21 November at the European Parliament.

Events

EU Water Innovation Conference 2019
11 December 2019 (Zaragoza, Spain)

Accelerating action to tackle water pollution and enhance EU preparedness to water-related climate change impacts Read more

Save the Date | Joint EFGCP-EFPIA multi-stakeholder discussion
15 January 2020 (Crowne Plaza Le Palace, Brussels)

Roadmap Initiative to Good Lay Summary Practices Read more

8th ACCELERATE paediatric oncology Conference
06 February 2020 (Brussels)

This important and much needed conference brings together a wide variety of stakeholders to address specific overarching... Read more

5th European Conference on Clinical Research
10 February 2020 (Amsterdam, The Netherlands)

A must-attend event for clinical research professionals who wish to develop and grow Read more

What we are reading

Finnish presidency: HTA revamp 'sufficiently well-received'
On 03 December 2019 (Politico Pro)

EU countries have generally been positive about the revisions that the Finnish presidency of the Council has proposed... Read more

The added value of PE
On 26 November 2019 (IMI PARADIGM)

Luca Li Bassi, Director General at the Italian Medicines Agency (AIFA), says it is a privileged perspective for regulators... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu